Title | An intervention to reduce sitting and increase light-intensity physical activity at work: Design and rationale of the 'Stand & Move at Work' group randomized trial. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Buman, MP, Mullane, SL, Toledo, MJ, Rydell, SA, Gaesser, GA, Crespo, NC, Hannan, P, Feltes, L, Vuong, B, Pereira, MA |
Journal | Contemp Clin Trials |
Volume | 53 |
Pagination | 11-19 |
Date Published | 2017 Feb |
ISSN | 1559-2030 |
Keywords | Accelerometry, Blood Glucose, Blood Pressure, Cholesterol, HDL, Efficiency, Environment Design, Exercise, Humans, Insulin, Interior Design and Furnishings, Job Satisfaction, Posture, Sedentary Behavior, Triglycerides, Workplace |
Abstract | <p><b>BACKGROUND: </b>American workers spend 70-80% of their time at work being sedentary. Traditional approaches to increase moderate-vigorous physical activity (MVPA) may be perceived to be harmful to productivity. Approaches that target reductions in sedentary behavior and/or increases in standing or light-intensity physical activity [LPA] may not interfere with productivity and may be more feasible to achieve through small changes accumulated throughout the workday METHODS/DESIGN: This group randomized trial (i.e., cluster randomized trial) will test the relative efficacy of two sedentary behavior focused interventions in 24 worksites across two states (N=720 workers). The MOVE+ intervention is a multilevel individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace. The STAND+ intervention is the MOVE+ intervention with the addition of the installation and use of sit-stand workstations to reduce sedentary behavior and enhance light-intensity physical activity opportunities. Our primary outcome will be objectively-measured changes in sedentary behavior and light-intensity physical activity over 12months, with additional process measures at 3months and longer-term sustainability outcomes at 24months. Our secondary outcomes will be a clustered cardiometabolic risk score (comprised of fasting glucose, insulin, triglycerides, HDL-cholesterol, and blood pressure), workplace productivity, and job satisfaction DISCUSSION: This study will determine the efficacy of a multi-level workplace intervention (including the use of a sit-stand workstation) to reduce sedentary behavior and increase LPA and concomitant impact on cardiometabolic health, workplace productivity, and satisfaction.</p><p><b>TRIAL REGISTRATION: </b>ClinicalTrials.gov Identifier: NCT02566317 (date of registration: 10/1/2015).</p> |
DOI | 10.1016/j.cct.2016.12.008 |
Alternate Journal | Contemp Clin Trials |
PubMed ID | 27940181 |
PubMed Central ID | PMC5274555 |
Grant List | R01 CA198971 / CA / NCI NIH HHS / United States |